User menu

An International Expanded Access Program (EAP) of RAD001 (everolimus) in patients with metastatic renal cell carcinoma (mRCC) who fail, or become intolerant of a prior vascular endothelial growth factor receptor (VEGFr) therapy : Abstract #7154

Bibliographic reference Grünwald, V. ; Rah, S.Y. ; Miller, K. ; Karakiewicz, P.I. ; Machiels, Jean-Pascal ; et. al. An International Expanded Access Program (EAP) of RAD001 (everolimus) in patients with metastatic renal cell carcinoma (mRCC) who fail, or become intolerant of a prior vascular endothelial growth factor receptor (VEGFr) therapy : Abstract #7154.15th Congress of the European-Cancer-Organization/34th Multidisciplinary Congress of the European-Society-for-Medical-Oncology (Berlin(Germany), du 20/09/2009 au 24/09/2009). In: EJC - Supplements, Vol. 7, no. 2, p. 440 (2009)
Permanent URL http://hdl.handle.net/2078.1/58706